| 1605314-85-9 |
头孢丙烯杂质N |
1605314-85-9 |
| Sitagliptin Impurity 27 |
西他列汀杂质27 |
1608491-98-0 |
| Tadalafil Impurity 33 |
他达那非二聚体杂质 |
1598416-03-5 |
| Tebipenem Pivoxil Impurity P9 |
泰比培南匹酯杂质P9 |
1595319-82-6 |
| JPDYIRZKEDRQOF-BTJKTKAUSA-N |
JPDYIRZKEDRQOF-BTJKTKAUSA-N |
1590417-47-2 |
| TubePharm10tm |
1-(2,6-二氟苄基)-5-[(二甲基氨基)甲基]-3-(6-甲氧基 - 3-哒嗪基)-6-(4-硝基苯基)-噻吩并[2,3-D]嘧啶-2,4(1H,3H)-二酮 |
1589503-96-7 |
| Vilanterol Impurity 23 |
Vilanterol Impurity 23 |
1582675-85-1 |
| Tolvaptan Impurity 26 |
Tolvaptan Impurity 26 |
1580889-36-6 |
| [1,1'-Biphenyl]-4-ethanol, α-(chloromethyl)-, (αS)- |
(S)-1 - ([1,1'-联苯] -4-基)-3-氯丙-2-醇 |
1573000-28-8 |
| Mizolastine Impurity 11 |
Mizolastine Impurity 11 |
1569097-23-9 |
| Pregabalin Impurity 49 |
Pregabalin Impurity 49 |
1568110-05-3 |
| 3,4-Dibromo-5-methyl-benzoic acid |
弗雷拉纳标准品016 |
1564638-18-1 |
| 2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1S,3R,5S)- |
沙格列汀(S,R,S,S)异构体 |
1564266-00-7 |
| 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5E)- |
他氟前列腺素杂质 DCP |
1563176-58-8 |
| Ponatinib-d8 |
纳替尼-D8 |
1562993-37-6 |
| Tolterodine EP Impurity G |
托特罗定EP杂质G |
1554029-91-2 |
| Btk inhibitor 1 (R enantioMer hydrochloride) |
3-(4-苯氧基苯基)-1-(3R)-3-哌啶基-1H-吡唑并[3,4-D]嘧啶-4-胺盐酸盐(1:1) |
1553977-42-6 |
| 2,3-dimethyl-4-Pyridinol N-oxide |
2,3-DIMETHYL-4-PYRIDINOL N-OXIDE |
1551185-85-3 |
| Topiroxostat Impurity 10 |
Topiroxostat Impurity 10 |
1549944-68-4 |
| Octreotide Impurity |
奥曲肽杂质 |
1546983-16-7 |
